Watts R G, Crispens M A, Howard T H
Department of Pediatrics, University of Alabama, Birmingham 35233.
Cell Motil Cytoskeleton. 1991;19(3):159-68. doi: 10.1002/cm.970190304.
Neutrophils change shape from round to polar and sequentially polymerize/depolymerize actin following chemotactic peptide activation in suspension. To study the relationship between changes in F-actin content and shape we altered the kinetics/extent of actin polymerization and depolymerization with tBOC peptide, cytochalasin D (CD), and low-dose FMLP, and determined the effect of these alterations on the temporal sequence of changes in neutrophil shape. F-actin was measured by FACS analysis of NBDphallacidin-stained cells and expressed as relative fluorescent intensity (RFI) compared to control (RFI = 1.00). Shape was determined by scanning electron microscopy. FMLP causes serial polymerization/depolymerization of actin (RFI = 1.00 +/- 0.04, 1.60 +/- 0.21, 1.10 +/- 0.18, and 1.05 +/- 0.14) associated with four distinct shapes (round-smooth, round-ruffled, blebbed, and polar) noted at 0, 30, 90, 300 sec respectively. Since blebbed and polar shapes appear concurrent with depolymerization and following polymerization, we determined whether depolymerization is required for polarization of cells. The kinetics of depolymerization were: (1) accelerated by tBOC addition at 45 sec, and (2) slowed by high concentrations of FMLP (greater than 10-7M) (300 sec RFI = 1.46). Neither change altered the time course of shape change. To determine whether duration of actin polymerization defines shape, polymerization was halted by addition of tBOC at 5, 10, 20, 30 sec after FMLP to block actin polymerization and shape was monitored at 300 sec. TBOC added 5-20 sec after FMLP limited neutrophil shape change to the blebbed form, while tBOC addition 30 sec following FMLP resulted in a polar shape at 300 sec. To determine whether the extent of actin polymerization affects the shape change sequence, polymerization was limited by (1) inhibition of polymerization with CD, (2) exposure of cells to low concentrations of FMLP (less than 10-9 M), and (3) interruption of polymerization with tBOC. Actin polymerization to RFI less than 1.35-fold basal results in blebbed shape; polymerization greater than 1.35-fold basal yields polar shape. The data show: (1) the human neutrophil demonstrates intermediate shapes when activated by chemotactic peptide, (2) depolymerization of F-actin does not determine shape, and (3) blebbed shape appears when actin polymerizes for greater than 5 sec; polar shape with polymerization greater than or equal to 30 sec to RFI greater than 1.35-fold basal. The data suggest actin polymerization is required for, and extent of polymerization determines, the shape of human neutrophils.
在悬浮液中,趋化肽激活后,中性粒细胞会从圆形变为极性,并依次进行肌动蛋白的聚合/解聚。为了研究F-肌动蛋白含量变化与形状之间的关系,我们用叔丁氧羰基(tBOC)肽、细胞松弛素D(CD)和低剂量的N-甲酰甲硫氨酰-亮氨酰-苯丙氨酸(FMLP)改变肌动蛋白聚合和解聚的动力学/程度,并确定这些改变对中性粒细胞形状变化时间序列的影响。通过对用NBD鬼笔环肽染色的细胞进行荧光激活细胞分选(FACS)分析来测量F-肌动蛋白,并将其表示为与对照相比的相对荧光强度(RFI)(RFI = 1.00)。通过扫描电子显微镜确定形状。FMLP会导致肌动蛋白的系列聚合/解聚(RFI分别为1.00±0.04、1.60±0.21、1.10±0.18和1.05±0.14),分别在0、30、90、300秒时出现四种不同形状(圆形-光滑、圆形-有褶皱、有泡状突起、极性)。由于有泡状突起和极性形状分别与解聚和聚合后同时出现,我们确定细胞极化是否需要解聚。解聚的动力学如下:(1)在45秒时添加tBOC会加速解聚,(2)高浓度的FMLP(大于10-7M)会减缓解聚(300秒时RFI = 1.46)。这两种变化都没有改变形状变化的时间进程。为了确定肌动蛋白聚合的持续时间是否决定形状,在FMLP作用后第5、10、20、30秒添加tBOC以阻止肌动蛋白聚合,然后在300秒时监测形状。FMLP作用后5 - 20秒添加tBOC将中性粒细胞形状变化限制为有泡状突起的形式,而FMLP作用后30秒添加tBOC在300秒时导致极性形状。为了确定肌动蛋白聚合的程度是否影响形状变化序列,通过以下方式限制聚合:(1)用CD抑制聚合,(2)使细胞暴露于低浓度的FMLP(小于10-9M),(3)用tBOC中断聚合。肌动蛋白聚合至RFI低于基础值的1.35倍会导致有泡状突起的形状;聚合大于基础值的1.35倍会产生极性形状。数据表明:(1)人类中性粒细胞在被趋化肽激活时呈现中间形状,(2)F-肌动蛋白的解聚不决定形状,(3)当肌动蛋白聚合超过5秒时出现有泡状突起的形状;聚合大于或等于30秒至RFI大于基础值的1.35倍时出现极性形状。数据表明肌动蛋白聚合是人类中性粒细胞形状形成所必需的,且聚合程度决定了其形状。